Beitsch Peter D, Hodge Charles W, Dowlat Kambiz, Francescatti Darius, Gittleman Mark A, Israel Philip, Nelson Jane C, Potruch Theodore, Snider Howard C, Whitworth Pat, Zannis Victor J, Patel Rakesh R
Dallas Breast Center, Dallas, Texas 75230, USA.
Breast J. 2009 Jan-Feb;15(1):93-100. doi: 10.1111/j.1524-4741.2008.00676.x.
Although two-thirds of invasive breast cancers and half of non-invasive breast cancers are amenable to lumpectomy, only about 70% of such patients choose breast conservation. Of that group, up to one-third do not follow-up with radiation therapy despite it being clinically indicated. The reasons include the patient's and surgeon's attitude toward breast conservation as well as the inconvenience and distance of a suitable radiation facility. The advent of shorter courses of radiation therapy may encourage more patients to seek adjuvant therapy. An increasingly popular and more convenient alternative to traditional whole-breast radiation therapy in patients with early-stage breast cancer is accelerated partial breast irradiation (APBI), for which the American Society of Breast Surgeons and the American Brachytherapy Society have promulgated guidelines for candidate selection. Although several methods are emerging, the most widely used brachytherapy technique utilizes the MammoSite single-catheter balloon brachytherapy device. In a best practices symposium convened in 2006, breast surgeons from academic and community practices with extensive experience in balloon brachytherapy developed general guidelines for integrating APBI into a breast surgical practice. Important considerations include patient age, histology, tumor location and size, and breast size. Thoughtful lumpectomy planning is essential to optimize balloon placement. Real-time sonographic guidance is essential as the surgeon should attend closely to volume excised and cavity shape. A cavity evaluation device can act as a place holder while patient suitability for APBI is considered. Many breast surgeons expert in this procedure insert the balloon catheter in the office either through a de novo skin entrance site removed from the lumpectomy incision or through the original incision. Optimally, insertion occurs within 2-3 weeks after lumpectomy. Close and continual communication with the radiation oncologist is essential to assure optimal outcomes. In this review, several key aspects of a successful APBI program from a surgeon's perspective as well as a consensus panel from a best practices symposium on the topic herein are highlighted.
尽管三分之二的浸润性乳腺癌和一半的非浸润性乳腺癌适合行肿块切除术,但只有约70%的此类患者选择保乳治疗。在这一群体中,高达三分之一的患者尽管临床表明需要放疗,但并未接受后续放疗。原因包括患者和外科医生对保乳治疗的态度,以及合适放疗机构的不便和距离。短疗程放疗的出现可能会鼓励更多患者寻求辅助治疗。对于早期乳腺癌患者,一种越来越受欢迎且更方便的传统全乳放疗替代方法是加速部分乳腺照射(APBI),美国乳腺外科医师学会和美国近距离放射治疗学会已发布了候选者选择指南。尽管有几种方法正在出现,但使用最广泛的近距离放射治疗技术是利用MammoSite单导管球囊近距离放射治疗装置。在2006年召开的一次最佳实践研讨会上,来自学术和社区医疗机构、在球囊近距离放射治疗方面有丰富经验的乳腺外科医生制定了将APBI纳入乳腺外科实践的一般指南。重要的考虑因素包括患者年龄、组织学、肿瘤位置和大小以及乳房大小。精心的肿块切除术规划对于优化球囊放置至关重要。实时超声引导必不可少,因为外科医生应密切关注切除体积和腔隙形状。在考虑患者是否适合APBI时,腔隙评估装置可作为占位器。许多精通此手术的乳腺外科医生在办公室通过远离肿块切除术切口的新皮肤入口部位或通过原切口插入球囊导管。最佳情况下,插入操作在肿块切除术后2至3周内进行。与放疗肿瘤学家密切且持续的沟通对于确保最佳结果至关重要。在本综述中,从外科医生的角度以及关于本文主题的最佳实践研讨会的共识小组突出了成功的APBI计划的几个关键方面。